Kim S, Okazaki S, Otsuka I, Shinko Y, Horai T, Shimmyo N, Hirata T, Yamaki N, Tanifuji T, Boku S, Sora I, Hishimoto A. Searching for biomarkers in schizophrenia and psychosis: Case-control study using capillary electrophoresis and liquid chromatography time-of flight mass spectrometry and systematic review of biofluid metabolites. Neuropsychopharmacol Rep. 2022; 42: 42-51
Okazaki S, Boku S, Watanabe Y, Otsuka I, Horai T, Morikawa R, Kimura A, Shimmyo N, Tanifuji T, Someya T, Hishimoto A. Pplymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia. PLoS One. 2022; e0265738
Sasaki H, Jono T, Fukuhara R, Honda K, Ishikawa T, Boku S, Takebayashi M. Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study. BMC Psychiatry. 2022; 22:354 https://doi.org/10.1186/s12888-022-03978-0
Koga Y, Miyako K, Kajitani N, Boku S, Takebayashi M. Comprehensive analysis of gene expression hippocampal astrocytes in a model of depression. Neuroscience 2022, San Diego, USA, Nov 12-16, 2022
Miyako K, Koga Y, Kajitani N, Boku S, Takebayashi M. Establishment of a clinical setting-associated behavioral model of ECT and investigation of the mechanism of action of ECT with focus on astrocytes. Neuroscience 2022, San Diego, USA, Nov 12-16, 2022
Yanagida Y, Nakachi Y, Kikkawa S, Kiyota E, Watanabe R, Murata Y, Sugawara H, Ishikawa T, Hashimoto M, Takano Y, Taki Y, Sakai N, Okamoto Y, Takebayashi M, Bundo M, Iwamoto K. Serotonin transporter promoter activity regulated by polymorphisms and DNA methylation affects depression and cognitive decline in old people: The Arao study. CINP 2022, Taipei, Taiwan, Jun 9-13, 2022